FMP
OncoCyte Corporation
OCX
NASDAQ
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
2.08 USD
-0.04 (-1.92%)
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system. OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
0001642380
US68235C2061
68235C107
15 Cushing
949 409 7600
US
43
Dec 30, 2015
Ms. Sandra O'Donald
Senior Vice President of Business Operat...
0
N/A
Dr. Michael D. West Ph.D.
Scientific Advisor, Co-Chief Executive O...
0
1953
Dr. Paul R. Billings FACP, M.D.
Consulting Chief Medical Officer
0
1952
Mr. Joshua Riggs
President, Chief Executive Officer & Dir...
504.63k
1983
Mr. James Liu
Senior Director, Controller & Principal ...
259.83k
1996
Ms. Andrea Susan James
Chief Financial Officer
0
N/A
Mr. Yuh-Min Chiang Ph.D.
Chief Technology Officer
0
N/A
Mr. Peter Hong
Vice President, General Counsel & Secret...
0
N/A
Dr. Ekkehard Schutz M.D., Ph.D.
Chief Science Officer
409.27k
N/A
As of December 31, 2024, the total employee count stands at 43, with compensation values reflecting the last fiscal year ending on that date. Pay encompasses salary, bonuses, etc., All figures are in USD.